NeilScottSadickMD

Clinical Trials

• Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System Start of enrollment: 2009 Dec 01

  Completed

  Not Applicable

• Treatment of Androgenetic Alopecia in Females, 9 Beam Start of enrollment: 2009 Oct 01

  Completed

  Not Applicable

• Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds Start of enrollment: 2010 Sep 01

  Completed

  Not Applicable

• Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair Start of enrollment: 2013 Dec 01

  Completed

  Not Applicable

• Poly-L-lactic Acid for Skin Quality Start of enrollment: 2013 Sep 01

  Completed

  Phase 4

• Evaluation of an Herbal-Based De-Pigmenting System Start of enrollment: 2013 Oct 01

  Completed

  Phase 4

• Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy Start of enrollment: 2014 Sep 01

  Completed

  Phase 2

• Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females Start of enrollment: 2016 Dec 01

  Completed

  Not Applicable

• enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars Start of enrollment: 2017 Jul 27

  Completed

  Not Applicable

• Rimegepant in Moderate Plaque-type Psoriasis Start of enrollment: 2021 Jan 19

  Recruiting

  Phase 2

  Roles: Contact

• Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane Injections Start of enrollment: 2022 Nov 01

  Not yet recruiting

  Not Applicable

  Roles: Contact

• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06

  Recruiting

  Phase 3

  Roles: Principal Investigator

• POC Study to Evaluate BSI-045B Monotherapy and BSI-045B add-on Therapy With Dupilumab in Atopic Dermatitis Start of enrollment: 2023 Jul 31

  Recruiting

  Phase 2

  Roles: Contact

• Join now to see all